Open AccessA PHASE III, RANDOMIZED, OPEN-LABEL, COMPARATIVE, MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF PROGRAF?? (TACROLIMUS)/MMF, MODIFIED RELEASE (MR) TACROLIMUS/MMF AND NEORAL?? (CYCLOSPORINE)/MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 12 MONTH RESULTS.
Author(s) -
AUTHOR_ID
Publication year - 2006
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200607152-00748
Subject(s) - tacrolimus , medicine , open label , safety profile , pharmacology , adverse effect , transplantation